Advertisement
Advertisement

CVS

CVS logo

CVS HEALTH CORPORATION

96.74
USD
Sponsored
-0.46
-0.47%
Sep 04, 15:59 UTC -4
Closed
exchange

After-Market

96.85

+0.11
+0.11%

CVS Earnings Reports

Positive Surprise Ratio

CVS beat 40 of 42 last estimates.

95%

Next Report

Date of Next Report
Oct 27, 2026
Estimate for Q3 26 (Revenue/ EPS)
$105.37B
/
$1.62
Implied change from Q2 26 (Revenue/ EPS)
-0.68%
/
-37.21%
Implied change from Q3 25 (Revenue/ EPS)
+2.43%
/
+1.25%

CVS HEALTH CORPORATION earnings per share and revenue

On Aug 05, 2026, CVS reported earnings of 2.58 USD per share (EPS) for Q2 26, beating the estimate of 1.87 USD, resulting in a 37.95% surprise. Revenue reached 106.10 billion, compared to an expected 101.12 billion, with a 4.93% difference. The market reacted with a -5.08% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 20 analysts forecast an EPS of 1.62 USD, with revenue projected to reach 105.37 billion USD, implying an decrease of -37.21% EPS, and decrease of -0.68% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
HealthEquity, Inc
Report Date
Aug 27, 2026 For Q2 27
Estimate
$1.20
Actual
$1.24
Surprise
+2.92%
logo
MiniMed Group, Inc. Common Stock
Report Date
Sep 01, 2026 For Q1 27
Estimate
$0.09
Actual
$0.00
Surprise
-100.00%
FAQ
For Q2 2026, CVS HEALTH CORPORATION reported EPS of $2.58, beating estimates by 37.95%, and revenue of $106.10B, 4.93% above expectations.
The stock price moved down -5.08%, changed from $104.42 before the earnings release to $99.12 the day after.
The next earning report is scheduled for Oct 27, 2026.
Based on 20 analysts, CVS HEALTH CORPORATION is expected to report EPS of $1.62 and revenue of $105.37B for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement